-
Mashup Score: 0Home - 10 month(s) ago
Cochrane UK is delighted to be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd September. We have chosen the theme ‘Forward together for trusted evidence’ to explore the challenges for the future around trustworthiness of healthcare data and information whilst also celebrating 30 years of producing…
Source: events.cochrane.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Changes in RECIST Tumor Measures Correlate Linearly With Survival in Patients Treated With Checkpoint Inhibitors - The ASCO Post - 11 month(s) ago
By The ASCO Post Staff Posted: 6/4/2023 9:00:00 AM Last Updated: 6/4/2023 5:51:01 AM The Response Evaluation Criteria in Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories—complete response, partial…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Home - 12 month(s) ago
Cochrane UK is delighted to be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd September. We have chosen the theme ‘Forward together for trusted evidence’ to explore the challenges for the future around trustworthiness of healthcare data and information whilst also celebrating 30 years of producing…
Source: events.cochrane.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Senior Biostatistician - EORTC - 2 year(s) ago
Skip to content The Senior Biostatistician works under the hierarchical supervision of the Head of the Statistics Department. He/she will be accountable for the statistical support to EORTC studies and research projects and is identified as supporting one or several EORTC Groups or Task Forces and/or…
Source: EORTCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
This cohort study examines whether randomized clinical trials of cancer treatment with negative findings that inform cancer care guidelines are recognized for their scientific relevance by the research community.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Now, he and colleagues have published another study on the impact of randomized clinical trials to determine if “practice-influencing” trials – those that are cited in clinical care guidelines – are as valuable as “non-practice influencing” trials. 4/8 https://t.co/GqUvDLvJTK
-
-
Mashup Score: 185Dr. Jeffrey Leek named VP and Chief Data Officer - 2 year(s) ago
Distinguished biostatistician and data science education leader Dr. Jeffrey Leek will be joining Fred Hutch in 2022 as vice president and chief data officer.
Source: Fred HutchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Colorectal Cancer Risk Assessment Tool - 3 year(s) ago
An interactive tool designed by scientists at the National Cancer Institute to estimate an individual’s risk of developing colorectal cancer.
Categories: Genetics, Latest HeadlinesTweet
Join us at #CochraneLondon to hear from Yemisi Takwoingi, one of our esteemed plenary speakers. 🌟 Get ready to be inspired by her expertise in diagnostic test reviews. #biostatistician ➡️ Learn more about the Cochrane Colloquium programme & speakers https://t.co/028IZymyqT https://t.co/TuwpzzU1aZ